ANTI-ORAI1 ANTIBODY

It is intended to provide a therapeutic and/or prophylactic agent for transplant rejections, immunological diseases, allergic diseases, inflammatory diseases, thrombosis, cancers, etc., targeting human Orai1. The present invention provides, for example, a pharmaceutical composition comprising an ant...

Full description

Saved in:
Bibliographic Details
Main Authors BABA, Daichi, KAGARI, Takashi, KOMAI, Tomoaki, ONODERA, Yoshikuni, KIMURA, Takako, AKI, Anri, NAGAOKA, Nobumi, TANAKA, Kento
Format Patent
LanguageEnglish
French
German
Published 06.01.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:It is intended to provide a therapeutic and/or prophylactic agent for transplant rejections, immunological diseases, allergic diseases, inflammatory diseases, thrombosis, cancers, etc., targeting human Orai1. The present invention provides, for example, a pharmaceutical composition comprising an antibody that specifically recognizes human Orai1 and has the activity of inhibiting human T cell activation.
Bibliography:Application Number: EP20150830516